B. Christopher Kim

B. Christopher Kim is an accomplished executive with extensive experience in the biotechnology sector. Currently serving as Executive Vice President and Board Member at Bridge Biotherapeutics, Inc., Kim leads the Boston Discovery Center and played a pivotal role in securing a €1.1 billion licensing deal with Boehringer Ingelheim. Kim holds advisory and board positions at several biotech companies, including Curie.Bio, Lipella Pharmaceuticals, and CytoReason. Additionally, Kim is a Managing Director at Novatio Ventures and a venture partner and co-founder at FreeMind Investments. Kim co-founded the Korea-Seoul Life Science Fund and has held key advisory roles in prominent pharmaceutical firms. With an educational background that includes an MBA from Carnegie Mellon University, a PhD from UT MD Anderson Cancer Center, and dual Bachelor's degrees from UC Irvine, Kim combines robust academic credentials with practical expertise in clinical-stage biotech development and corporate strategy.